Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27

FDA recall notice · announced June 5, 2019 · Avella Of Deer Valley, Inc. Store 38

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27

Reason for recall

Lack of assurance of sterility

Notes

Distribution: U.S.A. nationwide
Lot/code information: Lot #: 138-20191202@64, Exp 05/13/19
Quantity: 730 syringes
Status: Terminated
Products in this recall event:
- Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27 (D-1308-2019)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.